EX-21.1 2 mrkr-20211231xex21d1.htm EX-21.1

Exhibit 21.1

SUBSIDIARIES

Marker Cell Therapy, Inc.

GeneMax Pharmaceuticals, Inc.

GeneMax Pharmaceuticals Canada, Inc.